88Q.DE
Price:
$7.95
Market Cap:
$110.33M
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Industry
Biotechnology
IPO Date
2021-11-23
Stock Exchange
XETRA
Ticker
88Q.DE
According to 4basebio PLC’s latest financial reports and current stock price. The company's current PE Ratio is -7.04. This represents a change of 14.96% compared to the average of -6.12 of the last 4 quarters.
The mean historical PE Ratio of 4basebio PLC over the last ten years is -36.72. The current -7.04 PE Ratio has changed 1.82% with respect to the historical average. Over the past ten years (40 quarters), 88Q.DE's PE Ratio was at its highest in in the June 2025 quarter at -4.89. The PE Ratio was at its lowest in in the June 2019 quarter at -49.14.
Average
-36.72
Median
-20.20
Minimum
-98.28
Maximum
-10.93
Discovering the peaks and valleys of 4basebio PLC PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 17.75%
Maximum Annual PE Ratio = -10.93
Minimum Annual Increase = -59.50%
Minimum Annual PE Ratio = -98.28
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -12.87 | 17.75% |
| 2023 | -10.93 | -35.64% |
| 2022 | -16.98 | -27.48% |
| 2021 | -23.42 | -59.50% |
| 2020 | -57.82 | -41.17% |
The current PE Ratio of 4basebio PLC (88Q.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.59
5-year avg
-24.40
10-year avg
-36.72
4basebio PLC’s PE Ratio is less than Heidelberg Pharma AG (-5.66), greater than FamiCord AG (-8.96), less than BRAIN Biotech AG (-5.66), less than Zura Bio Limited (-5.27), less than LIMES Schlosskliniken AG (21.05), less than Healwell AI Inc (-5.91), less than MPH Health Care AG (-0.91), less than Mediclin AG (5.50), less than Apontis Pharma AG (140.00), less than H100 Group AB N (-2.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.66 | $132.40M | |
| -8.96 | $94.13M | |
| -5.66 | $66.20M | |
| -5.27 | $214.57M | |
| 21.05 | $96.75M | |
| -5.91 | $99.88M | |
| -0.91 | $104.47M | |
| 5.50 | $179.55M | |
| 140.00 | $91.63M | |
| -2.22 | $60.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 4basebio PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 4basebio PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is 4basebio PLC's PE Ratio?
How is the PE Ratio calculated for 4basebio PLC (88Q.DE)?
What is the highest PE Ratio for 4basebio PLC (88Q.DE)?
What is the 3-year average PE Ratio for 4basebio PLC (88Q.DE)?
What is the 5-year average PE Ratio for 4basebio PLC (88Q.DE)?
How does the current PE Ratio for 4basebio PLC (88Q.DE) compare to its historical average?